These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 19075264)

  • 21. High plasma YKL-40 level in patients with ovarian cancer stage III is related to shorter survival.
    Høgdall EV; Johansen JS; Kjaer SK; Price PA; Christensen L; Blaakaer J; Bock JE; Glud E; Høgdall CK
    Oncol Rep; 2003; 10(5):1535-8. PubMed ID: 12883737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High serum levels of YKL-40 in patients with systemic sclerosis are associated with pulmonary involvement.
    Nordenbaek C; Johansen JS; Halberg P; Wiik A; Garbarsch C; Ullman S; Price PA; Jacobsen S
    Scand J Rheumatol; 2005; 34(4):293-7. PubMed ID: 16195162
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High serum YKL-40 concentration is associated with cardiovascular and all-cause mortality in patients with stable coronary artery disease.
    Kastrup J; Johansen JS; Winkel P; Hansen JF; Hildebrandt P; Jensen GB; Jespersen CM; Kjøller E; Kolmos HJ; Lind I; Nielsen H; Gluud C;
    Eur Heart J; 2009 May; 30(9):1066-72. PubMed ID: 19270316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High levels of serum HER-2/neu and YKL-40 independently reflect aggressiveness of metastatic breast cancer.
    Jensen BV; Johansen JS; Price PA
    Clin Cancer Res; 2003 Oct; 9(12):4423-34. PubMed ID: 14555515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated pretreatment serum concentration of YKL-40-An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer.
    Thöm I; Andritzky B; Schuch G; Burkholder I; Edler L; Johansen JS; Bokemeyer C; Schumacher U; Laack E
    Cancer; 2010 Sep; 116(17):4114-21. PubMed ID: 20564116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preoperative serum YKL-40 is a marker for detection and prognosis of endometrial cancer.
    Diefenbach CS; Shah Z; Iasonos A; Barakat RR; Levine DA; Aghajanian C; Sabbatini P; Hensley ML; Konner J; Tew W; Spriggs D; Fleisher M; Thaler H; Dupont J
    Gynecol Oncol; 2007 Feb; 104(2):435-42. PubMed ID: 17023034
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes of biochemical markers of bone turnover and YKL-40 following hormonal treatment for metastatic prostate cancer are related to survival.
    Johansen JS; Brasso K; Iversen P; Teisner B; Garnero P; Price PA; Christensen IJ
    Clin Cancer Res; 2007 Jun; 13(11):3244-9. PubMed ID: 17545529
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum YKL-40 and colorectal cancer.
    Cintin C; Johansen JS; Christensen IJ; Price PA; Sørensen S; Nielsen HJ
    Br J Cancer; 1999 Mar; 79(9-10):1494-9. PubMed ID: 10188896
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma YKL-40, a new biomarker for atrial fibrillation?
    Henningsen KM; Therkelsen SK; Johansen JS; Bruunsgaard H; Svendsen JH
    Europace; 2009 Aug; 11(8):1032-6. PubMed ID: 19411674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. YKL-40, a marker of inflammation and endothelial dysfunction, is elevated in patients with type 1 diabetes and increases with levels of albuminuria.
    Rathcke CN; Persson F; Tarnow L; Rossing P; Vestergaard H
    Diabetes Care; 2009 Feb; 32(2):323-8. PubMed ID: 18957531
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma YKL-40, as a prognostic tumor marker in recurrent ovarian cancer.
    Dehn H; Høgdall EV; Johansen JS; Jørgensen M; Price PA; Engelholm SA; Høgdall CK
    Acta Obstet Gynecol Scand; 2003 Mar; 82(3):287-93. PubMed ID: 12694127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Early detection and prognosis of ovarian cancer using serum YKL-40.
    Dupont J; Tanwar MK; Thaler HT; Fleisher M; Kauff N; Hensley ML; Sabbatini P; Anderson S; Aghajanian C; Holland EC; Spriggs DR
    J Clin Oncol; 2004 Aug; 22(16):3330-9. PubMed ID: 15310777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. YKL-40 and matrix metalloproteinase-9 as potential serum biomarkers for patients with high-grade gliomas.
    Hormigo A; Gu B; Karimi S; Riedel E; Panageas KS; Edgar MA; Tanwar MK; Rao JS; Fleisher M; DeAngelis LM; Holland EC
    Clin Cancer Res; 2006 Oct; 12(19):5698-704. PubMed ID: 17020973
    [TBL] [Abstract][Full Text] [Related]  

  • 34. YKL-40, a biomarker of inflammation, is elevated in patients with type 2 diabetes and is related to insulin resistance.
    Rathcke CN; Johansen JS; Vestergaard H
    Inflamm Res; 2006 Feb; 55(2):53-9. PubMed ID: 16612564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum YKL-40 in risk assessment for colorectal cancer: a prospective study of 4,496 subjects at risk of colorectal cancer.
    Johansen JS; Christensen IJ; Jørgensen LN; Olsen J; Rahr HB; Nielsen KT; Laurberg S; Brünner N; Nielsen HJ
    Cancer Epidemiol Biomarkers Prev; 2015 Mar; 24(3):621-6. PubMed ID: 25597749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasma YKL-40 and recovery of left ventricular function after acute myocardial infarction.
    Hedegaard A; Ripa RS; Johansen JS; Jørgensen E; Kastrup J
    Scand J Clin Lab Invest; 2010 Apr; 70(2):80-6. PubMed ID: 20102300
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum YKL-40 levels as a prognostic factor in patients with locally advanced breast cancer.
    Yamac D; Ozturk B; Coskun U; Tekin E; Sancak B; Yildiz R; Atalay C
    Adv Ther; 2008 Aug; 25(8):801-9. PubMed ID: 18670741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High serum YKL-40 concentration is associated with severe bone disease in newly diagnosed multiple myeloma patients.
    Mylin AK; Abildgaard N; Johansen JS; Andersen NF; Heickendorff L; Standal T; Gimsing P; Knudsen LM
    Eur J Haematol; 2008 Apr; 80(4):310-7. PubMed ID: 18182077
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma YKL-40: a potential new cancer biomarker?
    Johansen JS; Schultz NA; Jensen BV
    Future Oncol; 2009 Sep; 5(7):1065-82. PubMed ID: 19792974
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated plasma YKL-40 and risk of infectious disease: a prospective study of 94665 individuals from the general population.
    Kjaergaard AD; Helby J; Johansen JS; Nordestgaard BG; Bojesen SE
    Clin Microbiol Infect; 2020 Oct; 26(10):1411.e1-1411.e9. PubMed ID: 31972315
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.